|
Real-time Estimate
Cboe BZX
18:06:01 04/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 312.75 USD | +2.23% |
|
+3.81% | +37.24% |
| 09-02 | FDA Center for Drug Evaluation & Research Issues Warning Letter to Jabil Inc | CI |
| 08-11 | Wall Street ends down as US-Iran peace optimism fades | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- JBL Stock
- Consensus Jabil Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
